Anemia and Kidney Health: Why They're Connected

Anemia — a shortage of healthy red blood cells, or of the haemoglobin they carry — is one of the most common issues that comes up in kidney health research, and the relationship works in both directions: anemia is a recognised risk factor for chronic kidney disease (CKD) progression, and it’s also one of the most frequent complications once CKD is established. Here’s what the data shows.

How common is anemia in CKD?

Across CKD populations broadly, anemia prevalence sits around 40–50% overall, but it climbs steeply with disease stage. Research on prevalence by eGFR band shows the pattern clearly, and it differs somewhat by sex: at an eGFR below 15 mL/min/1.73m², anemia prevalence reaches roughly 88% in men and 55% in women; in the Stage 4 band (eGFR 15–29), prevalence ranges from around 72% down to 48% in men and from about 35% down to 17% in women as eGFR improves within that band; and it continues to decline through Stage 3b and 3a as kidney function improves further.

Looking at prevalence by stage more broadly, one dataset puts it at 8–10% in Stage 1–2 (mild CKD), 20–40% in Stage 3 (moderate), 40–60% in Stage 4 (severe), and over 70% in Stage 5 / dialysis-dependent CKD.

Why kidney decline causes anemia

The primary mechanism is a deficiency in erythropoietin production. Erythropoietin is a hormone made by the kidneys that signals the bone marrow to produce red blood cells; as kidney tissue is damaged, erythropoietin output falls, and red blood cell production falls with it. Iron deficiency is also commonly cited as a major contributing factor alongside this hormonal shortfall, compounding the impaired red blood cell production.

A two-way relationship, and a growing body of risk

What makes this relationship particularly notable is that it isn’t purely one-directional. Anemia is associated with an increased risk of CKD progression itself, not just a downstream consequence of it — alongside increased risk of cardiovascular events and higher all-cause mortality. A cumulative-incidence analysis published in Clinical Kidney Journal found that the proportion of CKD patients developing new-onset anemia over roughly three years of follow-up rose steadily by baseline CKD stage, from lower rates at Stage 3a up through the highest cumulative incidence at Stage 5.

Anemia subtype also matters. A study using NHANES III follow-up data, published in the journal Renal Failure, compared survival outcomes across anemia types in CKD patients and found that functional iron deficiency anemia (FID) — a form where iron is present in the body but not effectively available for red blood cell production — was associated with meaningfully worse long-term survival than other anemia types or no anemia at all, over roughly 27–30 years of follow-up (P<0.001).

Anemia as a “risk multiplier” alongside heart failure

Perhaps the most striking data point on this topic comes from a large US analysis (a 5% Medicare sample covering roughly 1.1 million people) presented at the Heart Failure Society of America, which compared relative risk of two-year mortality across combinations of anemia, CKD, and heart failure. Using a healthy reference group as the baseline (relative risk = 1):

The pattern is clear: each condition on its own carries meaningfully elevated risk, but the combinations compound rather than simply add together, with the three-way combination of anemia, CKD, and heart failure carrying more than six times the mortality risk of the reference group.

Recognising the symptoms

Clinical descriptions of anemia in CKD commonly list extreme fatigue, shortness of breath, chest pain (which can signal a heart attack and warrants urgent attention), a rapid or irregular heartbeat, dizziness or lightheadedness on standing or moving, loss of appetite, and sleep problems. Because several of these symptoms — fatigue, breathlessness, poor appetite — are easy to attribute to everyday tiredness or ageing, anemia in the context of declining kidney function can go unrecognised for some time without routine blood testing.

Frequently asked questions

Does anemia cause kidney disease, or does kidney disease cause anemia? Both directions appear in the research. Reduced kidney function lowers erythropoietin production, which drives anemia — but anemia is also independently associated with a higher risk of CKD progressing further, making it both a consequence and a contributing factor.

Why does anemia become more common as CKD advances? Erythropoietin, the hormone that signals the bone marrow to produce red blood cells, is produced by the kidneys. As kidney tissue is progressively damaged, erythropoietin output declines, and iron deficiency frequently compounds the effect — together reducing the body’s capacity to produce healthy red blood cells.

Is all anemia in CKD the same? No. Research distinguishes between anemia types, including functional iron deficiency anemia, which some studies have linked to meaningfully worse long-term survival outcomes than other anemia types in people with CKD. Identifying the specific type typically requires blood testing interpreted by a doctor.

This article is for general information only and does not constitute medical advice. If you have been diagnosed with anemia, chronic kidney disease, or both, consult your doctor for appropriate testing and management — do not attempt to self-diagnose the type or cause of anemia.